Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease
Collaborative program with the U.S. Department of Veterans Affairs aims to validate GDNF as a first-in-class biologic for obesity and hepatic health. NEW YORK, Oct.... Read more.
Sunoco LP Announces Expected Closing Date for Acquisition of Parkland Corporation and NYSE Listing Information for SunocoCorp LLC (“SUNC”)
DALLAS, Oct. 27, 2025 /PRNewswire/ — Sunoco LP (NYSE: SUN) (“Sunoco” or the “Partnership”) announced today that the previously announced... Read more.
Magaya and Lune Partner to Deliver Integrated Emissions Intelligence Across Global Supply Chains
MIAMI, Oct. 27, 2025 /PRNewswire/ — Magaya Corporation, the leading freight management platform for logistics service providers, today announced a new technology... Read more.
Neptune Software: From Prompt to SAP App: How Neptune Lowers the Barrier to Enterprise Innovation
OSLO, Norway, Oct. 27, 2025 /PRNewswire/ — For years, SAP customers have wrestled with the same problem: how to deliver more apps, faster, without overwhelming... Read more.
EINC to Divest Two U.S. Auction Sites
Company to Focus on Licensing Technology and Canadian Growth TORONTO, Oct. 27, 2025 /PRNewswire/ – E Automotive Inc. (“EINC” or the “Company”),... Read more.
BTQ and ICTK Sign USD 15M Quantum-Secure Chip Development and Joint Investment Agreement to Advance Global Quantum-Safe Hardware
Complements Korea’s Quantum Defense Strategy and fast-tracks commercialization of a next-generation quantum-secure secure-element chip (QCIM) for Defense,... Read more.
Allstate issues new guidance to protect shoppers as identity scams surge ahead of the holidays
Allstate reports applications for new credit cards, loans and account setups peak in October during pre-Black Friday shopping, totaling more than $9M in potential... Read more.
Wed Society Names 2025 National Wedding of the Year
Birmingham couple selected from 5,000+ submissions and 19 national finalists after public Instagram voting; two runners‑up honored OKLAHOMA CITY, Oct. 27, 2025... Read more.
Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis
Building on 12-week findings, icotrokinra demonstrated clinically meaningful outcomes at Week 28 with 31.7% of patients achieving clinical remission and 38.1% showing... Read more.
KPS CAPITAL PARTNERS TO ACQUIRE CONTROLLING STAKE IN KETJEN FROM ALBEMARLE
NEW COMPANY WILL BE A GLOBAL LEADER IN ADVANCED CATALYSTS AND ADDITIVES FOR THE REFINING AND PETROCHEMICAL INDUSTRIES NEW YORK, Oct. 27, 2025 /PRNewswire/ —... Read more.